Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Basic & Clinical Pharmacology & Toxicology|February 12, 2022
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohortGeorgios Schoretsanitis, Céline Dubath, Claire Grosu, et al.
Schizophrenia Bulletin|July 15, 2025
Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to AripiprazoleCécile Gras, Marianna Piras, Setareh Ranjbar, et al.
Clinical Pharmacology and Therapeutics|May 12, 2025
Cytochrome P450 2D6 Poor Metabolizers and Risperidone Treatment Failure: A 1-Year Longitudinal StudyMarianna Piras, Setareh Ranjbar, Séverine Crettol, et al.
Translational Psychiatry|June 27, 2026
Psychotropic drug-induced weight gain and untargeted metabolomics: machine learning-driven results from a prospective cohort studyMarianna Piras, Gaëlle Magliocco, Setareh Ranjbar, et al.
European Journal of Nutrition|May 4, 2024
Self-reported caffeine consumption miss-matched consumption measured by plasma levels of caffeine and its metabolites: results from two population-based studiesNermine Laaboub, Setareh Ranjbar, Marie-Pierre F Strippoli, et al.
Archives of Women'S Mental Health|October 16, 2024
First episode depression during the perinatal period is associated with atopic diseases and persistently increased eosinophil and basophil levelsEn-Young N Wagner, Eva Maria Pichler, Mario Müller, et al.
Translational Psychiatry|November 1, 2025
Familial and genetic relationships of major depressive disorders and adiposity markers in the communityAlexandre Berney, Giorgio Pistis, Marie-Pierre F Strippoli, et al.
Schizophrenia Bulletin|September 19, 2025
CYP2D6 Genotypes Do Not Affect Clozapine Levels in a Large, Multicenter Cohort: Time Has Come to Revise Food and Drug Administration's Clozapine Packet InsertGeorgios Schoretsanitis, Nermine Laaboub, Séverine Crettol, et al.
BMC Psychiatry|May 17, 2022
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohortNermine Laaboub, Céline Dubath, Setareh Ranjbar, et al.
International Journal of Bipolar Disorders|April 7, 2022
Environmental factors in offspring of parents with mood disorders and their role in parent-child transmission: findings from a 14-year prospective high-risk studyFlore Moulin, Mehdi Gholam, Marie-Pierre F Strippoli, et al.
Pageof 6